VVT Med Inc. (TSXV:VVTM)

Canada · Delayed Price · Currency is CAD

0.3000

+0.0200 (7.14%)

At close: Jul 10, 2026

-34.78% (1Y)

Market Cap	21.78M
Revenue (ttm)	107.48K -40.3%
Net Income	-5.60M
EPS	-0.10
Shares Out	72.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	0.3000
Previous Close	0.2800
Day's Range	0.2600 - 0.3000
52-Week Range	0.1500 - 0.5600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 1, 2026

About VVT Med

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2007

Employees 8

Stock Exchange TSX Venture Exchange

Ticker Symbol VVTM

Full Company Profile

Financial Performance

In 2025, VVT Med's revenue was $89,000, a decrease of -81.91% compared to the previous year's $492,000. Losses were -$3.98 million, 282.3% more than in 2024.

Financial numbers in USD Financial Statements